Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 3/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.48 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | PDE4A | P27815 | 1/20 | 0.47 |
| ▸ | KDR | P35968 | 1/20 | 0.47 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.47 |
| ▸ | SYK | P43405 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.44 |
| ▸ | CDK2 | P24941 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | ATF1 | P18846 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | KCNH3 | Q9ULD8 | 1/20 | 0.43 |
| ▸ | ABL1 | P00519 | 1/20 | 0.43 |
| ▸ | BCR | P11274 | 1/20 | 0.43 |
| ▸ | CTSC | P53634 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28037898 | 0.88 | KCNH2 (0.54) | KCNH2SCN9AADORA3SLC6A2PDE4A | |
| SCHEMBL28051330 | 0.87 | ADORA3 (0.59) | APPKCNH2SCN9AADORA3SLC6A2 | |
| SCHEMBL5466853 | 0.83 | APP (0.60) | APPCHRNA7KDM4ESMN1; SMN2NFKB1 | |
| SCHEMBL27589799 | 0.81 | SMN1; SMN2 (0.65) | APPKCNH2SCN9AADORA3SLC6A2 | |
| SCHEMBL2352230 | 0.81 | ADORA3 (0.69) | KCNH2SCN9AADORA3SLC6A2PDE4A | |
| SCHEMBL28051498 | 0.81 | IDH2 (0.53) | KCNH2SCN9ASYKKDM4ECDK2 | |
| SCHEMBL13064959 | 0.81 | KDM4E (0.69) | KCNH2SCN9AADORA3SLC6A2PDE4A | |
| SCHEMBL28051328 | 0.80 | TRPV1 (0.58) | KDM4ETRPV1CDK2SMN1; SMN2KCNH3 | |
| SCHEMBL28051435 | 0.80 | KDM4E (0.56) | APPSYKKDM4EKCNH3CTSC | |
| SCHEMBL6033627 | 0.79 | APP (0.59) | APPKDRCHRNA7KDM4ECDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103254144-A | Cyanuric chloride derivative, and preparation method and application thereof | WUHAN INST TECHNOLOGY | 2013-08-21 | — | — | CN | claimed |
| CN-102746246-A | 2,4-dichloro-6-(4-aminobenzotrifluoride)-1,3,5-triazine and preparation method and application thereof | WUHAN INST TECHNOLOGY | 2012-10-24 | — | — | CN | claimed |
| CN-102442960-A | Cyanuric chloride derivative and preparation method and application thereof | WUHAN INST TECHNOLOGY | 2012-05-09 | — | — | CN | claimed |
| EP-2760843-B1 | SELECTIVE NR2B ANTAGONISTS | BRISTOL MYERS SQUIBB CO (US) | 2016-03-02 | — | — | EP | disclosed |
| US-8841301-B2 | Selective NR2B antagonists | BRISTOL-MYERS SQUIBB COMPANY (US) | 2014-09-23 | — | — | US | disclosed |
| EP-2760843-A2 | SELECTIVE NR2B ANTAGONISTS | Bristol-Myers Squibb Company (US) | 2014-08-06 | — | — | EP | disclosed |
| CN-103254144-A | Cyanuric chloride derivative, and preparation method and application thereof | WUHAN INST TECHNOLOGY | 2013-08-21 | — | — | CN | disclosed |
| WO-2013049164-A1 | SUBSTITUTED OCTAHYDROPYRROLO[1,2-a]PYRAZINES AS CALCIUM CHANNEL BLOCKERS | ABBVIE INC. (US) | 2013-04-04 | — | — | WO | disclosed |
| WO-2013048949-A2 | SELECTIVE NR2B ANTAGONISTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-04-04 | — | — | WO | disclosed |
| US-20130079338-A1 | Selective NR2B Antagonists | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-03-28 | — | — | US | disclosed |
| CN-102746246-A | 2,4-dichloro-6-(4-aminobenzotrifluoride)-1,3,5-triazine and preparation method and application thereof | WUHAN INST TECHNOLOGY | 2012-10-24 | — | — | CN | disclosed |
| CN-102442960-A | Cyanuric chloride derivative and preparation method and application thereof | WUHAN INST TECHNOLOGY | 2012-05-09 | — | — | CN | disclosed |
| EP-1685124-A1 | SUBSTITUTED NITROGEN-CONTAINING SIX-MEMBERED AMINO-HETEROCYCLES AS VANILLOID-1 RECEPTOR ANTAGONISTS FOR TREATING PAIN | MERCK SHARP & DOHME LTD. (GB) | 2006-08-02 | — | — | EP | disclosed |
| US-20050197342-A1 | Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain | HOLLINGWORTH GREGORY J (GB) | 2005-09-08 | — | — | US | disclosed |
| WO-2005047279-A1 | SUBSTITUTED NITROGEN-CONTAINING SIX-MEMBERED AMINO-HETEROCYCLES AS VANILLOID-1 RECEPTOR ANTAGONISTS FOR TREATING PAIN | MERCK SHARP & DOHME LIMITED (GB) | 2005-05-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130079338-A1 | Selective NR2B Antagonists | GRIN2B, GRIN2A, GRIN3A | APP 1124/4885KCNH2 923/4885SCN9A 295/4885 |
| US-20050197342-A1 | Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain | OPRL1, OPRK1, CNR1 | APP 4260/4885KCNH2 102/4885SCN9A 255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.